VivoSim Labs (VIVS) Accumulated Expenses (2011 - 2026)
VivoSim Labs (VIVS) posted Accumulated Expenses of $738000.0 for Q2 2026, down 24.77% on a QoQ basis from $981000.0 in Q1 2026, and up 1.51% year-over-year from $727000.0 in Q2 2025.
Analysis
VivoSim Labs (VIVS) Accumulated Expenses (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Accumulated Expenses for 16 years, with the latest figure at $738000.0 in Q2 2026.
- On a quarterly basis, Accumulated Expenses rose 1.51% year-over-year to $738000.0 in Q2 2026; TTM through Jun 2026 was $738000.0, a 1.51% increase from a year earlier, with the FY2026 full-year figure at $981000.0, down 19.98% from the prior year.
- Accumulated Expenses was $738000.0 for Q2 2026 at VivoSim Labs, down from $981000.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $2.8 million in Q1 2023, with the low at $404000.0 in Q2 2024.
- Average Accumulated Expenses over 5 years is $865611.1, with a median of $732500.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses surged 482.41% in 2023, then slumped 74.47% in 2024.
- Over 5 years, Accumulated Expenses stood at $646000.0 in 2022, then advanced by 12.54% to $727000.0 in 2023, then jumped by 39.61% to $1.0 million in 2024, then retreated by 19.41% to $818000.0 in 2025, then decreased by 9.78% to $738000.0 in 2026.
- The last three Accumulated Expenses figures came in at $738000.0 (Q2 2026), $981000.0 (Q1 2026), and $818000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 738,000.00 |
| Mar 31, 2026 | 981,000.00 |
| Dec 31, 2025 | 818,000.00 |
| Sep 30, 2025 | 771,000.00 |
| Jun 30, 2025 | 727,000.00 |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 879,000.00 |
| Jun 30, 2024 | 404,000.00 |
| Mar 31, 2024 | 727,000.00 |
| Dec 31, 2023 | 727,000.00 |
| Sep 30, 2023 | 666,000.00 |
| Jun 30, 2023 | 787,000.00 |
| Mar 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 646,000.00 |
| Sep 30, 2022 | 462,000.00 |
| Jun 30, 2022 | 670,000.00 |
| Mar 31, 2022 | 489,000.00 |
| Dec 31, 2021 | 926,000.00 |
| Sep 30, 2021 | 717,000.00 |